Share Name Share Symbol Market Type Share ISIN Share Description
Surgical Innovations Group Plc LSE:SUN London Ordinary Share GB0004016704 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 2.40 100,311 08:00:07
Bid Price Offer Price High Price Low Price Open Price
2.30 2.50 2.40 2.40 2.40
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 10.73 -2.60 -0.33 22
Last Trade Time Trade Type Trade Size Trade Price Currency
08:17:59 O 8,770 2.395 GBX

Surgical Innovations (SUN) Latest News

More Surgical Innovations News
Surgical Innovations Investors    Surgical Innovations Takeover Rumours

Surgical Innovations (SUN) Discussions and Chat

Surgical Innovations Forums and Chat

Date Time Title Posts
02/3/202121:03(Surging) Surgical Innovations5,470
13/10/201915:27Surgical Innovations : A New BOD & A New Future122
14/2/201221:44Where's the thread gone?1

Add a New Thread

Surgical Innovations (SUN) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Surgical Innovations trades in real-time

Surgical Innovations (SUN) Top Chat Posts

Surgical Innovations Daily Update: Surgical Innovations Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker SUN. The last closing price for Surgical Innovations was 2.40p.
Surgical Innovations Group Plc has a 4 week average price of 2.05p and a 12 week average price of 1.45p.
The 1 year high share price is 2.50p while the 1 year low share price is currently 1.05p.
There are currently 932,816,177 shares in issue and the average daily traded volume is 653,032 shares. The market capitalisation of Surgical Innovations Group Plc is £22,387,588.25.
buywell2: They did not put a number on the recent 5yr USA Trocar Deal with Microline unlike the one with USA Adler Surgical also 5yr and valued at $12M The market for Trocars is big in the USA , also specialist Microline in a BIG player in America and was not selling or making its own brand of Trocar That it chose SUN speaks volumes , the trocar market for SUN through Microline could be arguably bigger as SUN has yet newer trocars soon to come to market which presumably Microline will also sell into the USA Perhaps a number might then be put on the 5yr sales deal , $12M ? If so that would be $24M USA sales over 5 years = Nearly $5M a year added to turnover or around 3.5M GBP a year of which imo at least 1M would be profit Then there is the ROW to sell the new Trocar range into plus other new products coming to market
boonkoh: Everyone jumping into retail and travel shares.But the improving covid situation will benefit hospitals and surgeries first. Hospitals will empty out of Covid patients, so elective surgeries can ramp up.SUN is facing three amazing tailwinds. Huge boom in elective surgeries next two+ years, new products (Cellis, Dexter, etc) to sell this year vs last year. New expanded distribution in the USA.With so many things, growth vs 2019 is more than assured, yet the shares are being valued as though we'd only get back to 2019 levels.
xylemflow: Last week Green Surgery Challenge, this week US direct distribution of SUN ‘Green’ products..... Joe Biden Green agenda. Maybe some joined-up thinking going on finally at SUN?
boonkoh: This share moves in mysterious ways.After two buys of 1m shares at the full 2.2p asking, the ask now decreased to 2.1p.Oh well, time to just stop looking and hold the shares for the long term and check in 6 months time!
xylemflow: Another interesting announcement. Very topical. It looks like SUN is making a niche for itself in an area that will only grow.
buywell3: To any newbe to SUN A couple of points to think about from here on 1) Planned operations in the NHS have been getting cancelled for the last few years around the winter flu season when beds get full in hospitals. This has been made worse by Covid-19 and looks now imo to be an ongoing issue for the NHS and Government to sort out . 2) Cancellation of operations does NOT however mean that the work is lost unless of course the patient dies --- which regards to MIS the area of SUN operations is imo unlikely in the vast majority of cases so what it means is that the backlog of work stacks up It is fairly obvious now that there is a bed shortage in ICU's and also a staff shortage Ditto for nurses across other wards Not enough doctors, surgeons or Hospitals to cope with what will be the Covid endemic as we all learn to live a vaccine existance getting what imo will be at least 2 Covid-19 jabs a year until a cure is found . So the Government has to invest in technologies that can clear the backlog and keep pace with increase in work as more sick patients arrive at Hospitals MIS reduces LOS in Hospitals so it frees up beds and allows more patients to receive treatment MIS results in less complications after surgery so it saves money re claims and is better in patient outcomes a win/win MIS Robotic surgery has the potential to increase the output of operations carried out as robots do not get tired or go sick or take annual leave buywell expects to see a RNS from SUN very soon now to say that a certain Hospital/s with NHS Trust XXXX has leased yyy Dexters buywell expects such an RNS to be accompanied by investors buying SUN as such news sinks in buywell expects further RNS's to follow as other Hospitals and other NHS Trusts follow with a similar result
xylemflow: The spread is so wide because there just isn't much in the market - sellers think its got a lot more life in it and buyers are after a bargain. It is the circular problem of AIM lack of liquidity. Big spreads make a share illiquid, and illiquid shares have a big spread. Catch 22. At the moment, all of the trades are small. It needs a big investor to take a view on the future of this share and to hoover-up a load regardless of price (to a point). Once that happens there will be a lot of smaller shareholders keen to sell, creating a more liquid market at a higher price.... at least that is what I learned at business school!!
buywell3: buywell is into making predictions as some know to their cost and some know to their gain buywell predicts SUN will be sold within 3 years as of today buywells understanding is that there are some nifty new MIS products soon to be added to the SUN range of MIS surgical instruments Means more IP you see which is worth lots of lolly if it works as designed 3p next target for now
kenone: And a big boost to the share price
van zandt: May I say the same to most. I feel such excitement coming on!! No. Nothing to do with SUN share price. as ever regards VZ
Surgical Innovations share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Surgical I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210303 09:31:44